ARTICLE | Clinical News
OP-1 morphogenic protein: CBMI's partner completed patient accrual in its pivotal trial
January 15, 1996 8:00 AM UTC
Autograft requires two surgical procedures, to remove bone chips from a patient's hip and place them into the defect site to stimulate new bone growth. OP-1 requires a single surgical procedure.
The trial has a nine-month followup, with a 1997 PMA submission possible. ...